The role of reactive oxygen species (ROS) and cytochrome P-450 2E1 in the generation of carcinogenic etheno-DNA adducts

Redox Biology

Volumn 3, Issue , 2014, Pages 56-62

  Linhart, Kirsten ^a   Bartsch, Helmut ^b   Seitz, Helmut K ^c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Krankenhaus Salem   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Carcinogenesis; Cytochrome P450 2E1; Ethanol; Etheno DNA adducts; Lipidperoxidation products; Non alcoholic fatty liver disease

Indexed keywords

ALCOHOL; CARCINOGEN; CYTOCHROME P450 2E1; ETHENO DNA ADDUCT; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; DNA ADDUCT;

ALCOHOL LIVER DISEASE; ALCOHOLISM; CANCER RISK; CHRONIC INFLAMMATION; DISEASE ASSOCIATION; DNA DAMAGE; GENOTOXICITY; HUMAN; LIPID PEROXIDATION; LIVER CARCINOGENESIS; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; REVIEW; ANIMAL; CELL TRANSFORMATION; DNA ADDUCT; GENETICS; INFLAMMATION; LIVER; LIVER TUMOR; METABOLISM; MUCOSA; PATHOLOGY;

ANIMALS; CARCINOGENS; CELL TRANSFORMATION, NEOPLASTIC; CYTOCHROME P-450 CYP2E1; DNA ADDUCTS; DNA DAMAGE; ETHANOL; HUMANS; INFLAMMATION; LIVER; LIVER NEOPLASMS; MUCOUS MEMBRANE; NON-ALCOHOLIC FATTY LIVER DISEASE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 84912113044     PISSN: 22132317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redox.2014.08.009     Document Type: Review

References (92)

1. Albano E. Alcohol, oxidative stress and free radical damage. Proceedings of the Nutrition Society 2006, 65:278-290. http://www.ncbi.nlm.nih.gov/pubmed/16923312, 10.1079/PNS2006496.
2. Seitz H.K., Stickel F. Molecular mechanisms of alcohol-mediated carcinogenesis. Nature Reviews: Cancer 2007, 7:599-612. http://www.ncbi.nlm.nih.gov/pubmed/17646865, 10.1038/nrc2191.
3. Coussens L.M., Werb Z. Inflammation and cancer. Nature 2002, 420:860-867. http://www.ncbi.nlm.nih.gov/pubmed/12490959, 10.1038/nature01322.
4. Hussain S.P., Hofseth L.J., Harris C.C. Radical causes of cancer. Nature Reviews: Cancer 2003, 3:276-285. http://www.ncbi.nlm.nih.gov/pubmed/12671666, 10.1038/nrc1046.
5. Kawanishi S., Hiraku Y. Oxidative and nitrative DNA damage as biomarker for carcinogenesis with special reference to inflammation. Antioxidants and Redox Signaling 2006, 8:1047-1058. http://www.ncbi.nlm.nih.gov/pubmed/16771694, 10.1089/ars.2006.8.1047.
6. Mantovani A., Allavena P., Sica A., Balkwill F. Cancer-related inflammation. Nature 2008, 454:436-444. http://www.ncbi.nlm.nih.gov/pubmed/18650914, 10.1038/nature07205.
7. Ohshima H., Bartsch H. Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutation Research 1994, 305:253-264. http://www.ncbi.nlm.nih.gov/pubmed/7510036, 10.1016/0027-5107(94)90245-3.
8. Karin M., Lawrence T., Nizet V. Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell 2006, 124:823-835. http://www.ncbi.nlm.nih.gov/pubmed/16497591, 10.1016/j.cell.2006.02.016.
9. Lonkar P., Dedon P.C. Reactive species and DNA damage in chronic inflammation: reconciling chemical mechanisms and biological fates. International Journal of Cancer: Journal International du Cancer 2011, 128:1999-2009. http://www.ncbi.nlm.nih.gov/pubmed/21387284, 10.1002/ijc.25815.
10. Bartsch H., Nair J. Chronic inflammation and oxidative stress in the genesis and perpetuation of cancer: role of lipid peroxidation, DNA damage, and repair. Langenbeck's Archives of Surgery/Deutsche Gesellschaft für Chirurgie 2006, 391:499-510. http://www.ncbi.nlm.nih.gov/pubmed/16909291, 10.1007/s00423-006-0073-1.
11. Karin M., Greten F.R. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nature Reviews: Immunology 2005, 5:749-759. http://www.ncbi.nlm.nih.gov/pubmed/16175180, 10.1038/nri1703.
12. Zha S., Yegnasubramanian V., Nelson W.G., Isaacs W.B., De Marzo A.M. Cyclooxygenases in cancer: progress and perspective. Cancer Letters 2004, 215:1-20. http://www.ncbi.nlm.nih.gov/pubmed/15374627, 10.1016/j.canlet.2004.06.014.
13. Prescott S.M., White R.L. Self-promotion? Intimate connections between APC and prostaglandin H synthase-2. Cell 1996, 87:783-786. http://www.ncbi.nlm.nih.gov/pubmed/8945503, 10.1016/S0092-8674(00)81983-2.
14. Schmid K., Nair J., Winde G., Velic I., Bartsch H. Increased levels of promutagenic etheno-DNA adducts in colonic polyps of FAP patients. International Journal of Cancer: Journal International du Cancer 2000, 87:1-4. http://www.ncbi.nlm.nih.gov/pubmed/10861445, 10.1002/1097-0215(20000701)87:1<1::AID-IJC1>3.0.CO;2-C.
15. Williams C.S., Luongo C., Radhika A., Zhang T., Lamps L.W., Nanney L.B., Beauchamp R.D., et al. Elevated cyclooxygenase-2 levels in Min mouse adenomas. Gastroenterology 1996, 111:1134-1140. http://www.ncbi.nlm.nih.gov/pubmed/8831610, 10.1016/S0016-5085(96)70083-5.
16. Williams M.V., Lee S.H., Pollack M., Blair I.A. Endogenous lipid hydroperoxide-mediated DNA-adduct formation in min mice. Journal of Biological Chemistry 2006, 281:10127-10133. http://www.ncbi.nlm.nih.gov/pubmed/16449227, 10.1074/jbc.M600178200.
17. Marks F., Müller-Decker K., Fürstenberger G. A causal relationship between unscheduled eicosanoid signaling and tumor development: cancer chemoprevention by inhibitors of arachidonic acid metabolism. Toxicology 2000, 153:11-26. http://www.ncbi.nlm.nih.gov/pubmed/11090944, 10.1016/S0300-483X(00)00301-2.
18. Nair J., Fürstenberger G., Bürger F., Marks F., Bartsch H. Promutagenic etheno-DNA adducts in multistage mouse skin carcinogenesis: correlation with lipoxygenase-catalyzed arachidonic acid metabolism. Chemical Research in Toxicology 2000, 13:703-709. http://www.ncbi.nlm.nih.gov/pubmed/10956057, 10.1021/tx000045d.
19. Winter C.K., Segall H.J., Haddon W.F. Formation of cyclic adducts of deoxyguanosine with the aldehydes trans-4-hydroxy-2-hexenal and trans-4-hydroxy-2-nonenal in vitro. Cancer Research 1986, 46:5682-5686. http://www.ncbi.nlm.nih.gov/pubmed/3756915.
20. Chung F.L., Chen H.J., Nath R.G. Lipid peroxidation as a potential endogenous source for the formation of exocyclic DNA adducts. Carcinogenesis 1996, 17:2105-2111. http://www.ncbi.nlm.nih.gov/pubmed/8895475, 10.1093/carcin/17.10.2105.
21. El Ghissassi F., Barbin A., Nair J., et al. Formation of 1,N6-ethenoadenine and 3,N4-ethenocytosine by lipid peroxidation products and nucleic acid bases. Chemical Research in Toxicology 1995, 8:278-283. http://www.ncbi.nlm.nih.gov/pubmed/7766812, 10.1021/tx00044a013.
22. Vaca C.E., Wilhelm J., Harms-Ringdahl M. Interaction of lipid peroxidation products with DNA. A review. Mutation Research 1988, 195:137-149. http://www.ncbi.nlm.nih.gov/pubmed/3277035, 10.1016/0165-1110(88)90022-X.
23. Pryor W.A., Porter N.A. Suggested mechanisms for the production of 4-hydroxy-2-nonenal from the autoxidation of polyunsaturated fatty acids. Free Radical Biology and Medicine 1990, 8:541-543. http://www.ncbi.nlm.nih.gov/pubmed/2193853, 10.1016/0891-5849(90)90153-A.
24. Blair I.A. DNA adducts with lipid peroxidation products. Journal of Biological Chemistry 2008, 283:15545-15549. http://www.ncbi.nlm.nih.gov/pubmed/18285329, 10.1074/jbc.R700051200.
25. Sodum R.S., Chung F.L. Stereoselective formation of in vitro nucleic acid adducts by 2,3-epoxy-4-hydroxynonanal. Cancer Research 1991, 51:137-143. http://www.ncbi.nlm.nih.gov/pubmed/1703030.
26. Nair U., Bartsch H., Nair J. Lipid peroxidation-induced DNA damage in cancer-prone inflammatory diseases: a review of published adduct types and levels in humans. Free Radical Biology and Medicine 2007, 43:1109-1120. http://www.ncbi.nlm.nih.gov/pubmed/17854706, 10.1016/j.freeradbiomed.2007.07.012.
27. Chung F.L., Chen H.J., Nath R.G. Lipid peroxidation as a potential endogenous source for the formation of exocyclic DNA adducts. Carcinogenesis 1996, 17:2105-2111. http://www.ncbi.nlm.nih.gov/pubmed/8895475, 10.1093/carcin/17.10.2105.
28. Hiraku Y., Kawanishi S. Role of nitrative DNA damage in inflammation related carcinogenesis. Cancer and Inflammation Mechanisms: Chemical, Biological, and Chemical Aspects 2014, 41-59. John Wiley & Sons, Hoboken, NJ. Y. Hiraku, S. Kawanishi, H. Ohshima (Eds.).
29. Eberle G., Barbin A., Laib R.J., et al. N6-etheno-2'-deoxyadenosine and 3,N4-etheno-2'-deoxycytidine detected by monoclonal antibodies in lung and liver DNA of rats exposed to vinyl chloride. Carcinogenesis 1989, 10:209-212. http://www.ncbi.nlm.nih.gov/pubmed/2783395, 10.1093/carcin/10.1.209.
30. Frank A., Seitz H.K., Bartsch H., et al. Immunohistochemical detection of 1,N6-ethenodeoxyadenosine in nuclei of human liver affected by diseases predisposing to hepato-carcinogenesis. Carcinogenesis 2004, 25:1027-1031. http://www.ncbi.nlm.nih.gov/pubmed/14742317, 10.1093/carcin/bgh089.
31. Nair J., Nair U.J., Sun X., et al. Quantifying etheno-DNA adducts in human tissues, white blood cells, and urine by ultrasensitive (32)P-postlabeling and immunohistochemistry. Methods in Molecular Biology (Clifton, N.J.) 2011, 682:189-205. http://www.ncbi.nlm.nih.gov/pubmed/21057929, 10.1007/978-1-60327-409-8_14.
32. Nair J., Barbin A., Guichard Y., et al. N6-ethenodeoxyadenosine and 3,N4-ethenodeoxycytine in liver DNA from humans and untreated rodents detected by immunoaffinity/32P-postlabeling. Carcinogenesis 1995, 16:613-617. http://www.ncbi.nlm.nih.gov/pubmed/7697821, 10.1093/carcin/16.3.613.
33. Nair J., Godschalk R.W., Nair U., et al. Identification of 3,N(4)-etheno-5-methyl-2'-deoxycytidine in human DNA: A new modified nucleoside which may perturb genome methylation. Chemical Research in Toxicology 2012, 25:162-169. http://www.ncbi.nlm.nih.gov/pubmed/22148471, 10.1021/tx200392a.
34. Nair J., Srivatanakul P., Haas C., et al. High urinary excretion of lipid peroxidation-derived DNA damage in patients with cancer-prone liver diseases. Mutation Research 2010, 683:23-28. http://www.ncbi.nlm.nih.gov/pubmed/19822158, 10.1016/j.mrfmmm.2009.10.002.
35. Barbin A. Etheno-adduct-forming chemicals: from mutagenicity testing to tumor mutation spectra. Mutation Research 2000, 462:55-69. http://www.ncbi.nlm.nih.gov/pubmed/10767618, 10.1016/S1383-5742(00)00014-4.
36. Bartsch H., Barbin A., Marion M.J., Nair J., Guichard Y. Formation, detection, and role in carcinogenesis of ethenobases in DNA. Drug Metabolism Reviews 1994, 26:349-371. http://www.ncbi.nlm.nih.gov/pubmed/8082574, 10.3109/03602539409029802.
37. Basu A.K., Wood M.L., Niedernhofer L.J., Ramos L.A., Essigmann J.M. Mutagenic and genotoxic effects of three vinyl chloride-induced DNA lesions: 1,N6-ethenoadenine, 3,N4-ethenocytosine, and 4-amino-5-(imidazol-2-yl)imidazole. Biochemistry 1993, 32:12793-12801. http://www.ncbi.nlm.nih.gov/pubmed/8251500, 10.1021/bi00210a031.
38. Pandya G.A., Moriya M. N6-ethenodeoxyadenosine, a DNA adduct highly mutagenic in mammalian cells. Biochemistry 1996, 35:11487-11492. http://www.ncbi.nlm.nih.gov/pubmed/8784204, 10.1021/bi960170h.
39. Palejwala V.A., Rzepka R.W., Simha D., Humayun M.Z. Quantitative multiplex sequence analysis of mutational hot spots. Frequency and specificity of mutations induced by a site-specific ethenocytosine in M13 viral DNA. Biochemistry 1993, 32:4105-4111. http://www.ncbi.nlm.nih.gov/pubmed/8471617, 10.1021/bi00066a036.
40. Moriya M., Zhang W., Johnson F., Grollman A.P. Mutagenic potency of exocyclic DNA adducts: marked differences between Escherichia coli and simian kidney cells. Proceedings of the National Academy of Sciences of the United States of America 1994, 91:11899-11903. http://www.ncbi.nlm.nih.gov/pubmed/7991554, 10.1073/pnas.91.25.11899.
41. Levine R.L., Yang I.Y., Hossain M., Pandya G.A., Grollman A.P., Moriya M. Mutagenesis induced by a single 1,N6-ethenodeoxyadenosine adduct in human cells. Cancer Research 2000, 60:4098-4104. http://www.ncbi.nlm.nih.gov/pubmed/10945616.
42. Swenberg J.A., Fedtke N., Ciroussel F., Barbin A., Bartsch H. Etheno adducts formed in DNA of vinyl chloride-exposed rats are highly persistent in liver. Carcinogenesis 1992, 13:727-729. http://www.ncbi.nlm.nih.gov/pubmed/1576725, 10.1093/carcin/13.4.727.
43. Cheng K.C., Preston B.D., Cahill D.S., Dosanjh M.K., Singer B., Loeb L.A. The vinyl chloride DNA derivative N2,3-ethenoguanine produces G-A transitions in Escherichia coli. Proceedings of the National Academy of Sciences of the United States of America 1991, 88:9974-9978. http://www.ncbi.nlm.nih.gov/pubmed/1946466, 10.1073/pnas.88.22.9974.
44. Miller J.A., Miller E.C. The metabolic activation and nucleic acid adducts of naturally-occurring carcinogens: recent results with ethyl carbamate and the spice flavors safrole and estragole. British Journal of Cancer 1983, 48:1-15. http://www.ncbi.nlm.nih.gov/pubmed/6191767, 10.1038/bjc.1983.151.
45. Hu W., Feng Z., Eveleigh J., Iyer G., Pan J., Amin S., Chung F.L., et al. The major lipid peroxidation product, trans-4-hydroxy-2-nonenal, preferentially forms DNA adducts at codon 249 of human p53 gene, a unique mutational hotspot in hepatocellular carcinoma. Carcinogenesis 2002, 23:1781-1789. http://www.ncbi.nlm.nih.gov/pubmed/12419825, 10.1093/carcin/23.11.1781.
46. Nair J., Nair U.J., Sun X., Wang Y., Arab K., Bartsch H. Quantifying etheno-DNA adducts in human tissues, white blood cells, and urine by ultrasensitive (32)P-postlabeling and immunohistochemistry. Methods in Molecular Biology (Clifton, N.J.) 2011, 682:189-205. http://www.ncbi.nlm.nih.gov/pubmed/21057929, 10.1007/978-1-60327-409-8_14.
47. Bartsch H., Nair J. Lipid peroxidation-derived DNA adduts and the role in inflammation-related carcinogenesis. Cancer and Inflammation Mechanisms: Chemical, Biological and Clinical Aspects 2014, 61-74. John Wiley & Sons, Hoboken, NJ. Y. Hiraku, S. Kawanishi, H. Ohshima (Eds.).
48. Seitz H.K., Stickel F. Risk factors and mechanisms of hepatocarcinogenesis with special emphasis on alcohol and oxidative stress. Biological Chemistry 2006, 387:349-360. http://www.ncbi.nlm.nih.gov/pubmed/16606331, 10.1515/BC.2006.047.
49. Bautista A.P. Neutrophilic infiltration in alcoholic hepatitis. Alcohol (Fayetteville, N.Y.) 2002, 27:17-21. http://www.ncbi.nlm.nih.gov/pubmed/12062632, 10.1016/S0741-8329(02)00206-9.
50. 2 levels induce hepcidin via signal transducer and activator of transcription 3 (STAT3). Journal of Biological Chemistry 2012, 287:37472-37482. http://www.ncbi.nlm.nih.gov/pubmed/22932892, 10.1074/jbc.M112.358911.
51. Fujita N., Miyachi H., Tanaka H., et al. Iron overload is associated with hepatic oxidative damage to DNA in nonalcoholic steatohepatitis. Cancer Epidemiology, Biomarkers and Prevention: a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 2009, 18:424-432. http://www.ncbi.nlm.nih.gov/pubmed/19190144, 10.1158/1055-9965.EPI-08-0725.
52. Chamulitrat W., Spitzer J.J. Nitric oxide and liver injury in alcohol-fed rats after lipopolysaccharide administration. Alcoholism, Clinical and Experimental Research 1996, 20:1065-1070. http://www.ncbi.nlm.nih.gov/pubmed/8892528, 10.1111/j.1530-0277.1996.tb01947.x.
53. Lieber C.S., DeCarli L.M. Hepatic microsomal ethanol-oxidizing system. In vitro characteristics and adaptive properties in vivo. Journal of Biological Chemistry 1970, 245(10):2505-2512. http://www.ncbi.nlm.nih.gov/pubmed/4315645.
54. Lieber C.S. CYP2E1: from ASH to Nash. Hepatology Research: the Official Journal of the Japan Society of Hepatology 2004, 28(1):1-11. http://www.ncbi.nlm.nih.gov/pubmed/14734144, 10.1016/j.hepres.2003.08.001.
55. Oneta C.M., Lieber C.S., Li J.J., Rüttimann S., Schmid B., Lattmann J., Rosman A.S., Seitz H.K. Dynamics of cytochrome P4502E1 activity in man: induction by ethanol and disappearance during withdrawal phase. Journal of Hepatology 2002, 36(1):47-52. http://www.ncbi.nlm.nih.gov/pubmed/11804663, 10.1016/S0168-8278(01)00223-9.
56. Lieber C.S., Cao Q., DeCarli L.M., Leo M.A., Mak K.M., Ponomarenko A., Ren C., et al. Role of medium-chain triglycerides in the alcohol-mediated cytochrome P450 2E1 induction of mitochondria. Alcoholism, Clinical and Experimental Research 2007, 31:1660-1668. http://www.ncbi.nlm.nih.gov/pubmed/17681033, 10.1111/j.1530-0277.2007.00475.x.
57. Albano E., Clot P., Morimoto M., Tomasi A., Ingelman-Sundberg M., French S.W. Role of cytochrome P4502E1-dependent formation of hydroxyethyl free radical in the development of liver damage in rats intragastrically fed with ethanol. Hepatology (Baltimore, Md.) 1996, 23:155-163. http://www.ncbi.nlm.nih.gov/pubmed/8550035, 10.1002/hep.510230121.
58. Leung T.M., Nieto N. CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease. Journal of Hepatology 2013, 58:395-398. http://www.ncbi.nlm.nih.gov/pubmed/22940046, 10.1016/j.jhep.2012.08.018.
59. Dey A., Cederbaum A.I. Induction of cytochrome P450 2E1 promotes liver injury in ob/ob mice. Hepatology (Baltimore, Md.) 2007, 45:1355-1365. http://www.ncbi.nlm.nih.gov/pubmed/17538970, 10.1002/hep.21603.
60. Wang X., Lu Y., Cederbaum A.I. Induction of cytochrome P450 2E1 increases hepatotoxicity caused by Fas agonistic Jo2 antibody in mice. Hepatology (Baltimore, Md.) 2005, 42:400-410. http://www.ncbi.nlm.nih.gov/pubmed/16025513, 10.1002/hep.20792.
61. Pérez M.J., Cederbaum A.I. Proteasome inhibition potentiates CYP2E1-mediated toxicity in HepG2 cells. Hepatology (Baltimore, Md.) 2003, 37(6):1395-1404. http://www.ncbi.nlm.nih.gov/pubmed/12774019, 10.1053/jhep.2003.50228.
62. Lu Y., Zhuge J., Wang X., Bai J., Cederbaum A.I. Cytochrome P450 2E1 contributes to ethanol-induced fatty liver in mice. Hepatology (Baltimore, Md.) 2008, 47(5):1483-1494. http://www.ncbi.nlm.nih.gov/pubmed/18393316, 10.1002/hep.22222.
63. Morgan K., French S.W., Morgan T.R. Production of a cytochrome P450 2E1 transgenic mouse and initial evaluation of alcoholic liver damage. Hepatology (Baltimore, Md.) 2002, 36:122-134. http://www.ncbi.nlm.nih.gov/pubmed/12085356, 10.1053/jhep.2002.33720.
64. Gouillon Z., Lucas D., Li J., Hagbjork A.L., French B.A., Fu P., Fang C., et al. Inhibition of ethanol-induced liver disease in the intragastric feeding rat model by chlormethiazole. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 2000, 224:302-308. http://www.ncbi.nlm.nih.gov/pubmed/10964266, 10.1046/j.1525-1373.2000.22435.x.
65. Bradford B.U., Kono H., Isayama F., Kosyk O., Wheeler M.D., Akiyama T.E., Bleye L., et al. Cytochrome P450 CYP2E1, but not nicotinamide adenine dinucleotide phosphate oxidase, is required for ethanol-induced oxidative DNA damage in rodent liver. Hepatology (Baltimore, Md.) 2005, 41:336-344. http://www.ncbi.nlm.nih.gov/pubmed/15660387, 10.1002/hep.20532.
66. Wang Y., Millonig G., Nair J., Patsenker E., Stickel F., Mueller S., Bartsch H., Seitz H.K. Ethanol-induced cytochrome P4502E1 causes carcinogenic etheno-DNA lesions in alcoholic liver disease. Hepatology (Baltimore, Md.) 2009, 50(2):453-461. http://www.ncbi.nlm.nih.gov/pubmed/19489076, 10.1002/hep.22978.
67. Weltman M.D., Farrell G.C., Hall P., Ingelman-Sundberg M., Liddle C. Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis. Hepatology (Baltimore, Md.) 1998, 27:128-133. http://www.ncbi.nlm.nih.gov/pubmed/9425928, 10.1002/hep.510270121.
68. Abdelmegeed M.A., Banerjee A., Yoo S.H., et al. Critical role of cytochrome P450 2E1 (CYP2E1) in the development of high fat-induced non-alcoholic steatohepatitis. Journal of Hepatology 2012, 57:860-866. http://www.ncbi.nlm.nih.gov/pubmed/22668639, 10.1016/j.jhep.2012.05.019.
69. Chalasani N., Gorski J.C., Asghar M.S., et al. Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis. Hepatology (Baltimore, Md.) 2003, 37:544-550. http://www.ncbi.nlm.nih.gov/pubmed/12601351, 10.1053/jhep.2003.50095.
70. Fujii H., Kawada N. Inflammation and fibrogenesis in steatohepatitis. Journal of Gastroenterology 2012, 47:215-225. http://www.ncbi.nlm.nih.gov/pubmed/22310735, 10.1007/s00535-012-0527-x.
71. Roberts E.A. Pediatric nonalcoholic fatty liver disease (NAFLD): a "growing" problem?. Journal of Hepatology 2007, 46:1133-1142. http://www.ncbi.nlm.nih.gov/pubmed/17445934, 10.1016/j.jhep.2007.03.003.
72. Ruiz-Extremera Á, Carazo Á, Salmerón Á, et al. Factors associated with hepatic steatosis in obese children and adolescents. Journal of Pediatric Gastroenterology and Nutrition 2011, 53:196-201. http://www.ncbi.nlm.nih.gov/pubmed/21788762, 10.1097/MPG.0b013e3182185ac4.
73. Lerret S.M., Garcia-Rodriguez L., Skelton J., et al. Predictors of nonalcoholic steatohepatitis in obese children. Gastroenterology Nursing: the Official Journal of the Society of Gastroenterology Nurses and Associates 2011, 34:434-437. http://www.ncbi.nlm.nih.gov/pubmed/22129796, 10.1097/SGA.0b013e3182371356.
74. Nobili V., Parola M., Alisi A., Marra F., Piemonte F., Mombello C., Sutti S., et al. Oxidative stress parameters in paediatric non-alcoholic fatty liver disease. International Journal of Molecular Medicine 2010, 26:471-476. http://www.ncbi.nlm.nih.gov/pubmed/20818484.
75. Qin H., Teufel U., Engelmann G., et al. Detection of hepatic highly carcinogenic, exocyclic etheno-DNA-adducts in patients with alcoholic and non-alcoholic fatty liver disease and in children with non-alcoholic steatoheopatitis. Journal of Hepatology 2012, 56(Suppl. 2):S520. 10.1016/S0168-8278(12)61331-2.
76. Xu J., Lai K.K., Verlinsky A., Lugea A., French S.W., Cooper M.P., Ji C., et al. Synergistic steatohepatitis by moderate obesity and alcohol in mice despite increased adiponectin and p-AMPK. Journal of Hepatology 2011, 55:673-682. http://www.ncbi.nlm.nih.gov/pubmed/21256905, 10.1016/j.jhep.2010.12.034.
77. Wang Y., Seitz H.K., Wang X.D. Moderate alcohol consumption aggravates high-fat diet induced steatohepatitis in rats. Alcoholism, Clinical and Experimental Research 2010, 34(3):567-573. http://www.ncbi.nlm.nih.gov/pubmed/20028348, 10.1111/j.1530-0277.2009.01122.x.
78. Ascha M.S., Hanouneh I.A., Lopez R., et al. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology (Baltimore, Md.) 2010, 51:1972-1978. http://www.ncbi.nlm.nih.gov/pubmed/20209604, 10.1002/hep.23527.
79. Baan R., Straif K., Grosse Y., Secretan B., El Ghissassi F., Bouvard V., Altieri A., Cogliano V. Carcinogenicity of alcoholic beverages. Lancet: Oncology 2007, 8:292-293. WHO International Agency for Research on Cancer Monograph Working Group. http://www.ncbi.nlm.nih.gov/pubmed/17431955, 10.1016/S1470-2045(07)70099-2.
80. Visapää J.P., Götte K., Benesova M., Li J., Homann N., Conradt C., Inoue H., et al. Increased cancer risk in heavy drinkers with the alcohol dehydrogenase 1C*1 allele, possibly due to salivary acetaldehyde. Gut 2004, 53:871-876. http://www.ncbi.nlm.nih.gov/pubmed/15138216, 10.1136/gut.2003.018994.
81. Homann N., König I.R., Marks M., Benesova M., Stickel F., Millonig G., Mueller S., et al. Alcohol and colorectal cancer: the role of alcohol dehydrogenase 1C polymorphism. Alcoholism, Clinical and Experimental Research 2009, 33:551-556. http://www.ncbi.nlm.nih.gov/pubmed/19120062, 10.1111/j.1530-0277.2008.00868.x.
82. Millonig G., Wang Y., Homann N., Bernhardt F., Qin H., Mueller S., Bartsch H. Ethanol-mediated carcinogenesis in the human esophagus implicates CYP2E1 induction and the generation of carcinogenic DNA-lesions. International Journal of Cancer: Journal International du Cancer 2011, 128(3):533-540. http://www.ncbi.nlm.nih.gov/pubmed/20715111, 10.1002/ijc.25604.
83. Simanowski U.A., Suter P., Russell R.M., Heller M., Waldherr R., Ward R., Peters T.J., et al. Enhancement of ethanol induced rectal mucosal hyper regeneration with age in F344 rats. Gut 1994, 35:1102-1106. http://www.ncbi.nlm.nih.gov/pubmed/7926914, 10.1136/gut.35.8.1102.
84. Simanowski U.A., Homann N., Knühl M., Arce L., Waldherr R., Conradt C., Bosch F.X., et al. Increased rectal cell proliferation following alcohol abuse. Gut 2001, 49:418-422. http://www.ncbi.nlm.nih.gov/pubmed/11511565, 10.1136/gut.49.3.418.
85. Vincon P., Wunderer J., Simanowski U.A., Koll M., Preedy V.R., Peters T.J., Werner J., et al. Inhibition of alcohol-associated colonic hyperregeneration by alpha-tocopherol in the rat. Alcoholism, Clinical and Experimental Research 2003, 27:100-106. http://www.ncbi.nlm.nih.gov/pubmed/12544013, 10.1111/j.1530-0277.2003.tb02728.x.
86. Beland F.A., Benson R.W., Mellick P.W., Kovatch R.M., Roberts D.W., Fang J.L., Doerge D.R. Effect of ethanol on the tumorigenicity of urethane (ethyl carbamate) in B6C3f1 mice. Food and Chemical Toxicology: an International Journal Published for the British Industrial Biological Research Association 2005, 43:1-19. http://www.ncbi.nlm.nih.gov/pubmed/15582191, 10.1016/j.fct.2004.07.018.
87. Soffritti M., Belpoggi F., Cevolani D., Guarino M., Padovani M., Maltoni C. Results of long-term experimental studies on the carcinogenicity of methyl alcohol and ethyl alcohol in rats. Annals of the New York Academy of Sciences 2002, 982:46-69. http://www.ncbi.nlm.nih.gov/pubmed/12562628.
88. Watabiki T., Okii Y., Tokiyasu T., Yoshimura S., Yoshida M., Akane A., Shikata N., et al. Long-term ethanol consumption in ICR mice causes mammary tumor in females and liver fibrosis in males. Alcoholism, Clinical and Experimental Research 2000, 24:117S-122S. http://www.ncbi.nlm.nih.gov/pubmed/10803793.
89. Roy H.K., Gulizia J.M., Karolski W.J., Ratashak A., Sorrell M.F., Tuma D. Ethanol promotes intestinal tumorigenesis in the MIN mouse. Multiple intestinal neoplasia. Cancer Epidemiology, Biomarkers and Prevention: a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 2002, 11:1499-1502. http://www.ncbi.nlm.nih.gov/pubmed/12433735.
90. Chavez P.R., Lian F., Chung J., et al. Long-term ethanol consumption promotes hepatic tumorigenesis but impairs normal hepatocyte proliferation in rats. Journal of Nutrition 2011, 141:1049-1055. http://www.ncbi.nlm.nih.gov/pubmed/21490289, 10.3945/jn.110.136531.
91. Ye Q., Lian F., Chavez P.R., et al. Cytochrome P450 2E1 inhibition prevents hepatic carcinogenesis induced by diethylnitrosamine in alcohol-fed rats. Hepatobiliary Surgery and Nutrition 2012, 1:5-18.
92. Tsuchishima M., George J., Shiroeda H., et al. Chronic ingestion of ethanol induces hepatocellular carcinoma in mice without additional hepatic insult. Digestive Diseases and Sciences 2013, 58:1923-1933. http://www.ncbi.nlm.nih.gov/pubmed/23371017, 10.1007/s10620-013-2574-4.